Indication
Treatment of diabetic peripheral neuropathic pain. Ariclaim is indicated in adults.
Loading your page…
Loading your page…
Diabetic Neuropathies
Marketing Authorisation Holder: Eli Lilly Nederland B.V.
EMA Authorisation: 11/08/2004
INN: duloxetine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ariclaim: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.